Central Asset Investments & Management Holdings’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-3,960
Closed -$1.52M 73
2021
Q3
$1.52M Buy
+3,960
New +$1.46M 0.82% 32

Other funds holding MRNA

Central Asset Investments & Management Holdings's MRNA Position: Q4 2021 in Review

Central Asset Investments & Management Holdings sold out of Moderna (MRNA) in Q4 2021, closing a stake of 3,960 shares — an estimated $1.52M sold.

Central Asset Investments & Management Holdings first reported a position in MRNA in Q3 2021 and held it in 1 quarter. The position peaked at $1.52M in Q3 2021. 1,110 funds tracked by Wall St. Rank hold MRNA as of Q4 2021.

  • Central Asset Investments & Management Holdings reported no remaining Moderna position as of Q4 2021 after selling out during the quarter.
  • Central Asset Investments & Management Holdings sold 3,960 Moderna shares in Q4 2021, an estimated $1.52M.
  • Central Asset Investments & Management Holdings first reported a position in Moderna in Q3 2021 and held it in 1 quarter.
  • Central Asset Investments & Management Holdings's Moderna position peaked at $1.52M in Q3 2021.
  • 1,110 funds tracked by Wall St. Rank held Moderna as of Q4 2021.

Based on Central Asset Investments & Management Holdings's 13F filing for Q4 2021, filed 11 Feb 2022.